A Wealth of Experience

We have collaborated with our clients on projects to research hematology, hematologic treatments, and complications and comorbidities of hematologic diseases. Our experience includes:

  • Allogeneic cord blood therapy 
  • Anemia
  • Blood transfusions
  • Hemophilia A
  • Hemophilia B
  • Myelofibrosis
  • Neutropenia
  • Polycythemia Vera
  • Pulmonary and venous embolism
  • Thrombocytopenia

Types of Projects

We have implemented studies to help our clients develop strategies in the hematology market and to develop and gain 
market access for products to treat hematologic diseases and complications arising from treatment of hematologic diseases.

Recent projects have included:

Our Experts

Joan Fortuny
Director, Epidemiology
Isobel Pearson
Senior Director, Health Economics, Health Technology Assessment
Sorrel Wolowacz
Head, European Health Economics
Alicia Gilsenan
Vice President, Epidemiology
Caroline Ling
Executive Director and HTA Specialist, Market Access and Outcomes Strategy
James Kaye
Senior Director, Epidemiology
Lynda Doward
European Head, Patient-Centered Outcomes Assessment
Jin Yang
Associate Director, Market Access and Outcomes Strategy
Maria Fernandez
Senior Director, Market Access and Outcomes Strategy
Kati Copley-Merriman
Vice President, Market Access and Outcomes Strategy
Dana DiBenedetti
Executive Director, Patient-Centered Outcomes Assessment
Annete Njue
Senior Director, Market Access and Outcomes Strategy
Keith Davis
Senior Director, Health Economics
William L Herring
Senior Director, Health Economics
Xiaolei Zhou
Senior Director, Biostatistics
Shahnaz Khan
Executive Director, Market Access and Outcomes Strategy
Lia Gutierrez
Senior Director, Epidemiology
Chris Knight
Senior Director, Health Economics
Anne Heyes
Vice President, Head Market Access and Outcomes Strategy, Europe

Selected Recent Hematology Publications

Fortuny J, von Gersdorff G, Lassalle R, Linder M, Overbeek J, Reinold J, Toft G, Timmer A, Dress J, Blin P, Droz-Perroteau C, Ehrenstein V, Franzoni C, Herings R, Kollhorst B, Moore N, Odsbu I, Perez-Gutthann S, Schink T, Rascher K, Rasouliyan L, Rothman KJ, Saigi-Morgui N, Schaller M, Smits E, Forstner M, Intravenous Iron Consortium, Benichou J, Bircher AJ, Garbe E, Rampton DS, Gutierrez L. Use of intravenous iron and risk of anaphylaxis: a multinational observational post-authorisation safety study in Europe. Pharmacoepidemiol Drug Saf. 2021 Oct;30(10):1447-57. doi: 10.1002/pds.5319.